The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shamrock Finlease Ltd & PACs
Awaiting price reaction for this filing.
Shamrock Pharmachemi Private Limited, part of the promoter group of Shamrock Industrial Company Ltd, bought 2,68,000 equity shares (4.94%) of the company on March 28, 2025 through an off-market transaction. After this purchase, Shamrock Pharmachemi's individual holding rose from 4.68% (2,53,900 shares) to 9.62% (5,21,900 shares). On a consolidated basis including all 16 Persons Acting in Concert (PACs) such as the Khokhani family members and other Shamrock group entities, the promoter group's stake increased from 38.04% (20,64,869 shares) to 42.98% (23,32,869 shares) of the total equity capital of 54,28,414 shares. The transaction was disclosed under SEBI SAST and Insider Trading regulations.
This is a promoter group share purchase that strengthens the existing promoters' control in the company, pushing their combined holding closer to the 50% majority mark. It signals continued promoter confidence, though the off-market nature means there is no direct impact on stock liquidity or price discovery on the exchange.